Despite the many advances in clinical care for the treatment of acute myocardial infarction (MI) and heart failure (HF), cardiogenic shock (CS) survival remains unchanged at 40%. For MI patients alone, the 30-day mortality rate is 40-50%, and it has remained at this level for the last two decades.
Below are two novel trials exploring conditions of the aorta that are currently enrolling at Baylor Scott & White – The Heart Hospital Plano. These trials leverage our multi-disciplinary team approach, which brings Cardiothoracic and Vascular surgeons together in our TAA clinic for collaborative, simultaneous visits with each patient. This approach has proven time and again to better inform decisions surrounding patient care plans and help produce stronger outcomes.
